Flashmelt oral dosage formulation

CAFC
  • US 8,518,421 B2
  • Filed: 05/16/2011
  • Issued: 08/27/2013
  • Est. Priority Date: 04/12/2000
  • Status: Expired due to Fees
First Claim
Patent Images

1. A flash-melt pharmaceutical dosage form comprising a medicament, two superdisintegrants, a dispersing agent and a binder wherein said medicament is aripiprazole and wherein said dispersing agent is calcium silicate and wherein said superdisintegrants are crospovidone and croscarmellose sodium, wherein based on the total weight of said dosage form, said crospovidone comprises from about 6 to about 8 percent by weight and said croscarmellose sodium comprises from about 2 to about 4 percent by weight.

View all claims
    ×
    ×

    Thank you for your feedback

    ×
    ×